These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21278513)

  • 1. Surgical and local-regional treatment of "early" invasive breast cancer.
    Hetzel DJ
    Clin Obstet Gynecol; 2011 Mar; 54(1):141-9. PubMed ID: 21278513
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.
    Moffat FL
    J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377
    [No Abstract]   [Full Text] [Related]  

  • 5. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma.
    Dale PS; Williams JT
    Am Surg; 1998 Jan; 64(1):28-31; discussion 32. PubMed ID: 9457034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organ preserving treatment of breast cancer].
    Topuzov EG; Krasnozhon DA
    Vestn Khir Im I I Grek; 2004; 163(3):99-102. PubMed ID: 15317177
    [No Abstract]   [Full Text] [Related]  

  • 8. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-axillary breast cancer recurrences after sentinel node biopsy.
    van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
    J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting.
    Kini VR; White JR; Horwitz EM; Dmuchowski CF; Martinez AA; Vicini FA
    Cancer; 1998 Jan; 82(1):127-33. PubMed ID: 9428488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive breast cancer. Surgical treatment alternatives.
    Marchant DJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):659-79. PubMed ID: 7731640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical impact of extracapsular extension of axillary lymph node metastases in breast cancer].
    Zhang B; Cao WF; Zhao HM; Song YQ; Ning LS; Niu Y; Hao XS; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):790-4. PubMed ID: 20021837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sentinel lymph node biopsy in breast carcinoma. Can removal of the sentinel node replace axillary dissection?].
    Schalhorn B
    Fortschr Med; 1999 Feb; 117(5):22. PubMed ID: 10095307
    [No Abstract]   [Full Text] [Related]  

  • 15. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.
    Fisher B; Wolmark N; Bauer M; Redmond C; Gebhardt M
    Surg Gynecol Obstet; 1981 Jun; 152(6):765-72. PubMed ID: 7244951
    [No Abstract]   [Full Text] [Related]  

  • 17. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary carcinoma of the breast without axillary lymph node metastases.
    Fracchia AA; Rosen PP; Ashikari R
    Surg Gynecol Obstet; 1980 Sep; 151(3):375-8. PubMed ID: 7404307
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
    Harris EE; Hwang WT; Seyednejad F; Solin LJ
    Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.